coronavirus treatment

A potentially life-saving treatment for COVID-19 credited with helping save former President Trump recover from the virus is now available to he public, although many are not aware it is an option. NBC New York’s Rana Novini reports.

U.S. regulators have ended one of Eli Lilly’s COVID-19 antibody trials early after data suggested the drug was “unlikely to help” coronavirus patients recover.

The World Health Organization released the findings of their coronavirus therapeutics study on Friday, which studied the impact of drugs like remdesivir and hydroxychloroquine on treating hospitalized coronavirus patients.

Eli Lilly’s late-stage trial of its monoclonal antibody coronavirus treatment was paused by U.S. regulators over potential safety concerns.

President Donald Trump briefly left Walter Reed Medical Center in his motorcade to salute at supporters outside the hospital. Trump was admitted to Walter Reed for COVID treatment on Friday. Doctors have said the president is doing “well” and could return to the White House as early as Monday.

Doctors treating President Donald Trump for the coronavirus at Walter Reed Medical Center gave updates on the president’s treatment on Saturday morning. “At this time, the team and I are extremely happy with the progress the president has made,” said the president’s physician, Dr. Sean Conley.

With 74-year-old President Trump and 50-year-old first lady Melania Trump testing positive for the coronavirus, what are the best proven treatments for them and other patients?

The nearly 1 million people who have lost their lives to COVID-19 also have given the world a gift: a better understanding of how to treat the disease

Pharmaceutical giant Gilead says it plans to charge at least $2,300 for a single treatment course of Remdesivir, a drug shown to shorten recovery time for severely ill coronavirus patients.

A new study out of the University of Minnesota suggests that anti-malarial drug hydroxychloroquine has no effect on preventing patients from contracting the novel coronavirus.

Results from a phase three trial show that Remdesivir helps recovery in moderately-ill coronavirus patients.

There may be new hope for patients hospitalized with severe cases of COVID-19, as early data shows that transfusions of convalescent plasma can aid in recovery

Almost two months from the day she left her home on Long Island, Zoila Laserna, a mother of two from Long Island, walked out of a hospital in Kentucky, holding her husband’s hand. Laserna had gone to Kentucky March 11 to visit with her brother. While Diego, her husband of 23 years, remained at their home in New York. It…

Team coverage of the coronavirus pandemic.

At a press conference on Monday, Admiral Brett Giroir, assistant secretary for health, confirmed that HHS is working with a network of children’s hospitals and intensive care units to better understand the extreme coronavirus symptoms in infected children.

Research for a cure to the Coronavirus is fast and furious across the nation and right here in the tri-state. University Hospital in Newark is seeing some promising results from blood plasma donations from people who have recovered from COVID19. Brian Thompson reports.

When asked if he takes responsibility for the spike in calls to poison control centers around the country following his on-camera comments about bleach and disinfectant injection as a potential coronavirus treatment, President Donald Trump said, “I can’t imagine why.”

Singer Jon Bon Jovi paid a digital visit this week to a kindergarten class, where he helped students strengthen their songwriting skills.

Madalyn Connors became the first person on Long Island to donate her plasma, which can be used to help treat sick patients or help those most at-risk avoid contracting the virus

As patients with COVID-19 continue pouring into emergency departments and intensive care units across the nation, an old treatment that has been adapted for a new disease is now being tested in New York, NBC News reports.